Regeneron: What we know about the experimental coronavirus drug ... - dofaq.co
Regeneron: What we know about the experimental coronavirus drug ...
Regeneron to invest over $3 billion to boost US manufacturing
Amid industry's onshoring push, Regeneron taps Fujifilm Diosynth for $3B, 10-year commercial manufacturing team-up
FUJIFILM Diosynth Biotechnologies and Regeneron Sign 10-year, $3+ Billion U.S. Manufacturing Deal
What Analyst Projections for Key Metrics Reveal About Regeneron (REGN) Q1 Earnings
Regeneron announces FDA issues CRL for aflibercept 8 mg (Eylea HD) sBLA
J. Safra Sarasin Holding AG Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
FUJIFILM Diosynth Biotechnologies, Regeneron Sign $3B Manufacturing Agreement
Roche, Regeneron Announce Combined $56B Expansions As Tariffs Loom
Regeneron Inks $3 Billion Fujifilm Deal to Bolster US Drugmaking
Fujifilm Diosynth Biotechnologies & Regeneron Sign Manufacturing Agreement
REGENERON EXPANDS PRESENCE IN CANADA BY OPENING ITS FIRST HEADQUARTERS TO BETTER SERVE NEEDS OF CANADIANS WITH SERIOUS DISEASES
Regeneron price target lowered to $975 from $1,004 at Truist
Regeneron turns to CDMO Fujifilm to boost US manufacturing capacity
FDA rejection of extended dosing interval is another piece of bad news for Regeneron’s Eylea HD
Regeneron announces FDA accepted Priority Review sBLA for EYLEA HD
Regeneron receives complete response letter for Eylea extended dosing
Sanofi and Regeneron's high-flying Dupixent on course for an 'inflection year' in COPD
Regeneron to Report Q1 Earnings: What's in Store for the Stock?
Analysts Estimate Regeneron (REGN) to Report a Decline in Earnings: What to Look Out for
